-

FUJIFILM Irvine Scientific Adds Key Products to Its Life Sciences Portfolio from FUJIFILM Wako Chemicals U.S.A.

  • Additional products in lab automation, lab chemicals and LAL expand complete solutions available directly from FUJIFILM Irvine Scientific to customers in US and Europe
  • Sales agreement aligns business and commercial operations to maximize customer benefit

SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, today announced further expansion of its product portfolio and enhanced services through the alignment of specific commercial operations with its sister company, FUJIFILM Wako Chemicals U.S.A., Corp. (FUJIFILM Wako Chemicals). Effective October 1, 2024, products from three divisions within the FUJIFILM Wako Chemicals organization — Lab Automation, Lab Chemicals, LAL Group — will be promoted directly from FUJIFILM Irvine Scientific to customers in the United States and Europe.

Both companies carry a rich history of offering quality products and services to their respective customer bases. The creation of a single, global commercial organization through FUJIFILM Irvine Scientific, will provide an expanded suite of products including cell culture solutions, laboratory chemicals, clinical diagnostic reagents, and laboratory automation software and services that will benefit all who work in life sciences.

Each company will maintain distinct business operations for product development, manufacturing facilities, and quality standards, but sales will be driven by FUJIFILM Irvine Scientific’s robust Life Sciences business unit.

Since 1970, FUJIFILM Irvine Scientific has been serving customers developing and manufacturing biopharmaceuticals, cell and gene therapy, and regenerative medicine for life science research and drug discovery. With a global network of sales and support operations across the United States, Europe, and Asia, FUJIFILM Irvine Scientific is well positioned to ensure efficient distribution of FUJIFILM Wako products. FUJIFILM Wako Pure Chemical Corporation has a long history in the markets they serve and will continue to sell directly to their customers in Asia.

Through the past several years, the Life Sciences Business Division of FUJIFILM Corporation has been creating synergies within the Fujifilm Group to become more customer-centric in its ability to offer complete solutions tailored for a wide range of customers within life sciences.

In 2020, FUJIFILM Irvine Scientific began selling iCell products from FUJIFILM Cellular Dynamics, and now we are excited to bring together the right mix of products from all of these Fujifilm teams, leveraging our collective expertise to offer our partners a breadth of life science solutions in one single destination,said Yutaka Yamaguchi, general manager of Life Sciences Business Division, FUJIFILM Corporation.We are listening to what our partners are asking for and FUJIFILM life sciences companies will continue working together to expand services needed for their future success in the field.

For more information about FUJIFILM Irvine Scientific’s product portfolio, please visit https://irvinesci.com.

Contacts

Zyme Communications
Jake Brown
Tel: +44(0)7759 162147
Email: jake.brown@zymecommunications.com

FUJIFILM Irvine Scientific, Inc.


Release Versions

Contacts

Zyme Communications
Jake Brown
Tel: +44(0)7759 162147
Email: jake.brown@zymecommunications.com

More News From FUJIFILM Irvine Scientific, Inc.

Fujifilm Rebrands Life Sciences Companies to Strengthen Position as Strategic Partners for Life, Offering End-to-End Solutions

TOKYO--(BUSINESS WIRE)--FUJIFILM Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive solutions that span all stages of therapeutic development from discovery through to commercialization, today announced new names and identities as part of a strategic positioning effort. The Group Companies’ new names, collaborative strategic focus, and structural alignment reflects Fujifilm’s commitment to Life Sciences, offering fully integrated...

FUJIFILM Irvine Scientific Sells its Medical Media Business to Astorg

SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the life science and medical markets, today announced it entered into an agreement to sell its Medical Media Business Unit (MBU) to Astorg, a leading pan-European private equity firm with an extensive track record in global healthcare investments. This strategic acquisition builds on Astorg’s recent take-private of Hamilton Thorne, and simultaneou...

FUJIFILM Irvine Scientific Develops Oceo Rover: The First Automated Single-Use Hydration System for Media and Buffers

SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the development of Oceo Rover, a first-of-its-kind* single-use technology system, that enables manufacturers of biopharmaceuticals to improve bioprocessing workflows by automating and simplifying the hydration of media, feeds, and buffers. The automated Oce...
Back to Newsroom